tirzepatide clinicaltrials.gov on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Long-Term Safety of Tirzepatide: What

Unimolecular peptides with dual GIP/GLP-1 receptor agonism have been developed to improve metabolic efficacy and therapeutic index beyond what incretin mono-agonists can achieve (44, 63)

Inhibition of ferroptosis attenuates tissue damage and improves long-term outcomes after traumatic brain injury in mice

Retatrutide may become the preferred option for patients who need more aggressive weight management or who have specific conditions like fatty liver disease that benefit from glucagon receptor activation

Isoflavones, including Daidzin, are well-absorbed and metabolized into conjugates in the liver before being excreted through urine, where they contribute to bladder protection

If appetite is very low or side effects are limiting food variety, ask for clinical or dietetic advice